Agrawal Sundeep 4

What Happened

• Sundeep Agrawal, a director of PAVmed Inc. (PAVM), received a grant of 13,930 restricted shares on April 2, 2026. The shares were issued at $0.00 per share (total purchase value $0) as an award under the company’s equity plan — this is a compensation award, not an open-market purchase.

Key Details

• Transaction date: April 2, 2026 (reported on Form 4 filed April 3, 2026).
• Transaction type/code: Award/Grant (A) of 13,930 restricted common shares at $0.00.
• Vesting and forfeiture: The shares vest on a single date — May 20, 2029 — and are subject to forfeiture if the service requirement is not met (per footnote).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Reported the next day (timely under Form 4 rules).

Context

• These are restricted (unvested) shares granted as compensation under PAVmed’s Long-Term Incentive Equity Plan. Such awards are common for directors and provide future upside if the director remains in service and the shares vest; they do not represent an immediate cash investment or sale.
• Because the award vests in 2029, it does not indicate a near-term change in insider selling or buying behavior.